Quick answer
PT-141 (bremelanotide) is a seven-residue cyclic melanocortin peptide, and its purity testing has to confirm three things: the ring is closed, the C-terminus is a free acid rather than an amide, and the main HPLC peak is the whole story.
- Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH; molecular formula C50H68N14O10, average mass about 1,025 Da
- Closest relative: melanotan-II (about 1,024 Da), which differs only by an amidated C-terminus, so about 1 Da apart
- Uncyclized precursor: appears 18 Da higher than the target
- Methods: reversed-phase HPLC for purity, mass spectrometry for identity; see HPLC vs. mass spectrometry
- Documents: lot-level reports in the CoA library; product page: PT-141 research vial
Research Use Only. For laboratory research use only; not for human consumption.
What is being tested: the PT-141 structure
PT-141 is a constrained cyclic peptide, and confirming a lot's sequence, cyclization and purity is the analytical starting point for melanocortin-receptor research. The sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH: a seven-residue peptide closed into a ring by a lactam bond between the aspartic acid and lysine side chains. It is identical to melanotan-II except at the C-terminus, where PT-141 has a free carboxylic acid in place of an amide. The compound's receptor biology is covered in the PT-141 research overview, and an introduction for newcomers is in what is PT-141.
| Feature | PT-141 | Melanotan-II |
|---|---|---|
| Core ring | Asp-His-D-Phe-Arg-Trp-Lys lactam | Same |
| N-terminus | Acetyl-norleucine | Same |
| C-terminus | Free carboxylic acid (-OH) | Amide (-NH2) |
| Average mass | About 1,025 Da | About 1,024 Da |
| Receptor profile in research | More MC4R-selective | Broader melanocortin activity |
Every analytical question below follows from this table: the two compounds are nearly identical, and a cyclic product has a linear counterpart one water molecule heavier.
Reversed-phase HPLC
HPLC resolves correctly formed PT-141 from linear intermediate and other synthesis-related byproducts, with the resulting purity figure interpreted per understanding HPLC purity. The free acid makes PT-141 slightly more polar than its amidated parent under typical acidic conditions, so the two can be resolved with a well-chosen gradient. Other species to look for include cyclic dimers from the ring-closing step and oxidized tryptophan forms, which elute earlier than the main peak.
Impurity classes specific to this molecule
- Linear precursor: peptide in which the Asp-Lys lactam never formed
- Cyclic dimers: two chains linked head-to-tail or side-chain to side-chain during cyclization, roughly twice the mass
- Oxidized tryptophan: +16 Da (and sometimes +32 Da) species from the indole side chain
- D/L stereo-variants: the D-Phe residue is deliberate; epimerization at other centers during coupling gives diastereomers with very similar mass
- Deletion sequences: peptides missing a residue because a coupling step failed
Mass spectrometry for identity
Because PT-141 is derived from the melanotan-II scaffold, mass spectrometry is important for confirming a lot is genuinely the more MC4R-selective PT-141 sequence rather than the broader-acting parent. The theoretical average mass of PT-141 is about 1,025 Da, against about 1,024 Da for melanotan-II. A difference of roughly 1 Da demands good mass accuracy and careful reading of the isotope pattern, which is why this pair is a useful test of an analytical report's quality. Linear, uncyclized precursor appears 18 Da higher.
In electrospray ionization, a peptide this size usually appears as the singly charged ion [M+H]+ and often also as [M+2H]2+ because of the basic arginine and lysine-derived sites. A report should state which ion was matched and whether the number given is monoisotopic or average mass; the two differ by a few tenths of a dalton at this size, which is large enough to confuse a PT-141 versus melanotan-II comparison. A higher-resolution instrument resolves the isotope envelopes cleanly and removes the ambiguity. The sibling analysis is in melanotan-II purity testing.
Why receptor selectivity depends on verified identity
PT-141's research value as a probe for central MC4R signaling depends on it being the correct, distinct compound. Misidentification against its parent scaffold would compromise any selectivity-based comparison, because a contaminating melanocortin agonist with broader receptor activity can contribute signal at MC1R, MC3R or MC5R that gets attributed to the wrong molecule. In practice this means receptor-profiling experiments should cite the lot's analytical data, not only its label. The model systems in which the two compounds are compared are summarized in the melanotan-II research overview, and the buyer's side of the question is in where to buy PT-141 for research.
Reading the PT-141 chromatogram
HPLC purity for PT-141 is reported as area percent: the main peak's share of all UV-absorbing material detected, normally at 214–220 nm. Three things make that number trustworthy.
- The method is stated. Column chemistry, mobile phases and gradient slope determine what counts as a separate impurity.
- The trace is clean. A flat baseline and a main peak free of fronting, tailing or shoulders; shoulders hint at co-eluting species.
- The integration table is complete. Every minor peak is accounted for, so the percentage reflects the whole sample and not a selectively drawn window.
Because tryptophan and the aromatic D-Phe and His residues absorb at 280 nm and 254 nm to differing extents, comparing a trace at two wavelengths can also reveal impurities that absorb differently from the main species.
What an HPLC percentage leaves out
Two quantities are easy to confuse: purity and content. Purity is the proportion of UV-absorbing peptide that is the target molecule. Content is the proportion of the dry powder that is peptide at all, once counter-ions and residual water are subtracted. A lot can be very pure and still carry a meaningful salt and moisture fraction, which matters when preparing standards by mass. The peptide calculator is a convenient way to plan reconstitution volumes and resulting concentrations (mg of peptide divided by mL of solvent).
| Measured quantity | Question it answers | Typical method |
|---|---|---|
| Purity | What fraction of the peptide signal is PT-141? | RP-HPLC, area percent |
| Identity | Does the mass match the cyclic, free-acid structure? | ESI mass spectrometry |
| Net content | What fraction of the powder is peptide? | Amino acid analysis or nitrogen content |
| Water | How much moisture is in the powder? | Karl Fischer titration |
Documentation to expect
A lot-specific certificate of analysis with HPLC purity and mass-spec identity is the minimum; see how to read a CoA. A useful PT-141 certificate is specific and traceable. It should show:
- The lot number, linking the document to a physical vial
- Chromatographic purity with the underlying trace and method
- Mass-spectrometric identity, with theoretical and measured values side by side
- Who ran the tests and when
Lot-level documents are available from the CoA library. The V8 PT-141 research vial page lists a 10 mg size, the formula C50H68N14O10, and a ≥98% HPLC purity specification, supplied as lyophilized powder.
Keeping a verified lot verified
Verified purity is not permanent. PT-141 stored as dry powder in cold, dark conditions holds its profile far longer than material kept in solution, where hydrolysis, oxidation and adsorption to container surfaces proceed more quickly. The product page lists refrigerated storage at 2–8 °C, with −20 °C for longer holds, protected from heat, moisture and light. Recording reconstitution dates, minimizing freeze-thaw cycles, and keeping a retained aliquot for re-analysis gives a lab a way to rule material degradation in or out when a result looks anomalous. An oxidized tryptophan peak (+16 Da) growing between two analyses is a typical sign of a storage problem rather than a synthesis one.
Frequently asked questions
How do PT-141 and melanotan-II differ chemically?
Only at the C-terminus: PT-141 ends in a free acid and melanotan-II in an amide. The ring, the core residues, and the N-terminal acetyl group are the same.
Can mass spectrometry reliably separate two peptides 1 Da apart?
Yes, with adequate resolution and calibration. The monoisotopic peaks are distinct, and combining the mass result with chromatographic retention gives two independent lines of evidence.
What does a signal 18 Da above the expected mass mean?
It indicates peptide in which the lactam ring has not formed, since ring closure eliminates one water molecule. Such material lacks the constrained shape the cyclic compound is studied for.
What does a +16 Da peak suggest?
Most likely a single oxidation, commonly of the tryptophan side chain. It can arise during synthesis, but growth of this peak between repeat analyses points to storage or handling.
Is a high HPLC purity enough to confirm a lot is PT-141?
No. HPLC measures how clean the sample is, not what it is. Two near-identical molecules, such as PT-141 and melanotan-II, need mass spectrometry to be told apart.
Why do some certificates give two different mass values?
Monoisotopic and average masses differ by a few tenths of a dalton for a peptide this size. A good report states which was used and compares like with like.
What does V8 Peptides list for PT-141?
The product page lists a 10 mg lyophilized vial with a ≥98% HPLC purity specification. Lot documents, where published, are in the CoA library.
Research Use Only. For laboratory research use only; not for human consumption. Supplied strictly for laboratory research and development. This article is research education, not usage guidance.
References
- V8 Peptides. PT-141 research overview.
- V8 Peptides. Melanotan-II purity testing.
- V8 Peptides. Understanding HPLC purity.
- V8 Peptides. HPLC vs. mass spectrometry.
- V8 Peptides. How to read a CoA.
- V8 Peptides. PT-141 research vial.
